Active Ingredient(s):Cefepime FDA Approved: * January 18, 1996 Pharm Company: *BRISTOL MYERS SQUIBB Category:Antibiotics
Cefepime is a fourth-generation cephalosporin antibiotic with the ability to cross the blood–brain barrier. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. A 2007 meta-analysis suggested when data of trials were combined, mortality was increased in people treated with cefepime compared with other β-lactam antibiotics. In response, the...
* May have multiple approval dates, manufacturers, or labelers.
Maxipime 1 g/1 Intravenous Injection, Powder, for Solution